You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 020386


✉ Email this page to a colleague

« Back to Dashboard


NDA 020386 describes COZAAR, which is a drug marketed by Organon and is included in one NDA. It is available from one supplier. Additional details are available on the COZAAR profile page.

The generic ingredient in COZAAR is losartan potassium. There are thirty-nine drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the losartan potassium profile page.
Summary for 020386
Tradename:COZAAR
Applicant:Organon
Ingredient:losartan potassium
Patents:0
Pharmacology for NDA: 020386
Medical Subject Heading (MeSH) Categories for 020386
Suppliers and Packaging for NDA: 020386
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COZAAR losartan potassium TABLET;ORAL 020386 NDA Organon LLC 78206-121 78206-121-01 90 TABLET, FILM COATED in 1 BOTTLE (78206-121-01)
COZAAR losartan potassium TABLET;ORAL 020386 NDA Organon LLC 78206-122 78206-122-01 30 TABLET, FILM COATED in 1 BOTTLE (78206-122-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Apr 14, 1995TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Apr 14, 1995TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Oct 13, 1998TE:ABRLD:Yes

Expired US Patents for NDA 020386

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon COZAAR losartan potassium TABLET;ORAL 020386-003 Oct 13, 1998 ⤷  Sign Up ⤷  Sign Up
Organon COZAAR losartan potassium TABLET;ORAL 020386-003 Oct 13, 1998 ⤷  Sign Up ⤷  Sign Up
Organon COZAAR losartan potassium TABLET;ORAL 020386-001 Apr 14, 1995 ⤷  Sign Up ⤷  Sign Up
Organon COZAAR losartan potassium TABLET;ORAL 020386-001 Apr 14, 1995 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.